The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Edwards Lifesciences Corp’s current trading price is -12.88% away from its 52-week high, while its distance from the 52-week low is 30.51%. The stock’s price range for this period has been between $58.93 and $88.28 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 5.24 million for the day, a number notably higher than the average daily volume of 4.27 million over the last three months.
The stock price for Edwards Lifesciences Corp (EW) currently stands at $76.91. The stock experienced a substantial increase in the last session, hitting $95.0 after starting at $76.91. The stock’s lowest price was $61.0 before closing at $76.3.
Edwards Lifesciences Corp’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $88.28 on 07/24/24 and a low of $58.93 for the same time frame on 07/25/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Edwards Lifesciences Corp (EW) has experienced a quarterly rise of 8.94% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 45.12B and boasts a workforce of 15800 employees.
Edwards Lifesciences Corp: What Analysts Are Saying
As of right now, 11 analysts are rating Edwards Lifesciences Corp as a BUY, 5 of the polled analysts branded the stock as an OVERWEIGHT, 17 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 74.09, with a change in price of +5.51. Similarly, Edwards Lifesciences Corp recorded 4,483,064 in trading volume during the last 100 days, posting a change of +7.72%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for EW stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.07.
EW Stock Stochastic Average
Edwards Lifesciences Corp’s raw stochastic average for the past 50 days is presently 69.28%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 44.80%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 49.34% and 53.33%, respectively.
EW Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -11.09%. However, over the past six months, we’ve seen a weaker performance of 9.92%. The price of EW fallen by 2.11% over the last 30 days. And in the last five days, it has surged by 1.01%.
